{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:14:46Z","timestamp":1789614886198,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.exer.2003.12.007","type":"journal-article","created":{"date-parts":[[2004,2,3]],"date-time":"2004-02-03T10:09:03Z","timestamp":1075802943000},"page":"767-776","source":"Crossref","is-referenced-by-count":116,"title":["Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug"],"prefix":"10.1016","volume":"78","author":[{"given":"Yasutaka","family":"Takagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Shimazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Kageyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Matsugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B'Ann T.","family":"Gabelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2003.12.007_BIB1","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/S0021-9258(17)41991-0","article-title":"Cloning and expression of a cDNA for the human prostanoid FP receptor","volume":"269","author":"Abramovitz","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2003.12.007_BIB2","first-page":"527","article-title":"Comparative phase III clinical trial of latanoprost and timolol in patients with elevated intraocular pressure","volume":"23","author":"Alm","year":"1995","journal-title":"Adv. Prostaglandin Thromboxane Leukot. Res."},{"key":"10.1016\/j.exer.2003.12.007_BIB3","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/S0039-6257(97)80016-1","article-title":"Phase III latanoprost studies in Scandinavia, the United Kingdom and the United States","volume":"41","author":"Alm","year":"2000","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2003.12.007_BIB4","first-page":"135","article-title":"Simultaneous measurements of changing intraocular pressure and outflow facility in the vervet monkey by constant pressure infusion","volume":"3","author":"B\u00e1r\u00e1ny","year":"1964","journal-title":"Invest. Ophthalmol."},{"key":"10.1016\/j.exer.2003.12.007_BIB5","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/00061198-200210000-00017","article-title":"Pressure dependence of uveoscleral outflow","volume":"11","author":"Becker","year":"2002","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.exer.2003.12.007_BIB6","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00061198-200302000-00017","article-title":"Some thoughts on the pressure dependence of uveoscleral flow","volume":"12","author":"Bill","year":"2003","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.exer.2003.12.007_BIB7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0002-9394(00)00843-6","article-title":"Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics","volume":"131","author":"Brubaker","year":"2001","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2003.12.007_BIB8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/02713688109001850","article-title":"Reduction of intraocular pressure in normal and glaucomatous primate (Aotus trivirgatus) eyes by topically applied prostaglandin F2\u03b1","volume":"1","author":"Camras","year":"1981","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2003.12.007_BIB9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0161-6420(96)30749-5","article-title":"Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. A six-month, masked, multicenter trial in the United States","volume":"103","author":"Camras","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2003.12.007_BIB10","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1476-5381.1989.tb12682.x","article-title":"Characterization of the prostanoid receptor profile of enprostil and isomersin smooth muscle and platelets in vitro","volume":"98","author":"Eglen","year":"1989","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.exer.2003.12.007_BIB11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archopht.1991.01080060143044","article-title":"Outflow facility and its response to pilocarpine decline in aging rhesus monkeys","volume":"109","author":"Gabelt","year":"1991","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2003.12.007_BIB12","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1167\/iovs.02-0569","article-title":"Aqueous humor dynamics and trabecular meshwork and anterior ciliary muscle morphologic changes with age in rhesus monkeys","volume":"44","author":"Gabelt","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2003.12.007_BIB13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0014-4835(90)90174-S","article-title":"The effect of prostaglandin F2\u03b1 on trabecular outflow facility in cynomolgus monkeys","volume":"51","author":"Gabelt","year":"1990","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2003.12.007_BIB14","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1006\/exer.1994.1149","article-title":"Apraclonidine and brimonidine effects of anterior ocular and cardiovascular physiology in normal and sympathectomized monkeys","volume":"59","author":"Gabelt","year":"1994","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2003.12.007_BIB15","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1210\/en.136.8.3430","article-title":"Cloning of a receptor for prostaglandin F2\u03b1 from the ovine corpus luteum","volume":"136","author":"Graves","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.exer.2003.12.007_BIB16","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/108076801753266802","article-title":"Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist","volume":"17","author":"Hellberg","year":"2001","journal-title":"J. Ocular. Pharmacol. Ther."},{"key":"10.1016\/j.exer.2003.12.007_BIB17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0002-9394(14)70870-0","article-title":"Hypertrichosis and increased pigmentation of eyelashes and adjacent hair in the region of the ipsilateral eyelids of patients treated with unilateral topical latanoprost","volume":"124","author":"Johnstone","year":"1997","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2003.12.007_BIB18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3109\/02713688509020033","article-title":"Pharmacological testing in the laser-induced monkey glaucoma model","volume":"4","author":"Lee","year":"1985","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.exer.2003.12.007_BIB19","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1600-0420.1997.tb00401.x","article-title":"Effects on intraocular pressure and aqueous flow of various dose regimens of latanoprost in human eyes","volume":"75","author":"Lind\u00e9n","year":"1997","journal-title":"Acta Ophthalmol. Scand."},{"key":"10.1016\/j.exer.2003.12.007_BIB20","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/archopht.1980.01020030538022","article-title":"\u2018Minified\u2019 Goldmann applanating prism for tonometry in monkeys and humans","volume":"98","author":"Kaufman","year":"1980","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2003.12.007_BIB21","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/0024-3205(95)98577-3","article-title":"Pyrroloquinoline quinone (PQQ) inhibits the expression of tyrosinase mRNA by \u03b1-melanocyte stimulating hormone in murine B16 melanoma cells","volume":"56","author":"Kosano","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.exer.2003.12.007_BIB22","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archopht.1996.01100140137004","article-title":"A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension: A 12-week study","volume":"114","author":"Mishima","year":"1996","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2003.12.007_BIB23","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1248\/bpb.26.1691","article-title":"New fluoroprostaglandin F2\u03b1 derivatives with prostanoid FP-receptor agonistic activity as potent ocular-hypotensive agents","volume":"26","author":"Nakajima","year":"2003","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.exer.2003.12.007_BIB24","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0002-9394(01)01177-1","article-title":"Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension","volume":"132","author":"Netland","year":"2001","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2003.12.007_BIB25","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0952-3278(93)90179-Z","article-title":"SC-46275: a potent and highly selective agonist at the EP3 receptor","volume":"49","author":"Savage","year":"1993","journal-title":"Prostaglandins Leukot. Essent. Fatty Acids"},{"key":"10.1016\/j.exer.2003.12.007_BIB26","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1211\/0022357991772989","article-title":"[3H]AL-5848 ([3H]9\u03b2-(+)-Fluprostenol). Carboxylic acid of travoprost (AL-6221), a novel FP prostaglandin to study the pharmacology and autoradiographic localization of the FP receptor","volume":"51","author":"Sharif","year":"1999","journal-title":"J. Pharmac. Pharmacol."},{"key":"10.1016\/j.exer.2003.12.007_BIB27","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.1016\/S0039-6257(01)00219-3","article-title":"Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure","volume":"45","author":"Sherwood","year":"2001","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2003.12.007_BIB28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0003-2697(86)90327-1","article-title":"In situ melanin assay for MSH using mouse B16 melanoma cells in culture","volume":"159","author":"Siegrist","year":"1986","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.exer.2003.12.007_BIB29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0014-4835(84)90044-7","article-title":"A method for near-continuous determination of aqueous humor flow; effects of anaesthetics, temperature and indomethacin","volume":"39","author":"Sperber","year":"1984","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2003.12.007_BIB30","first-page":"513","article-title":"Preclinical pharmacology of latanoprost, a phenyl-substituted PGF2\u03b1 analogue","volume":"23","author":"Stjernschantz","year":"1995","journal-title":"Adv. Prostaglandin Thromboxane Leuket. Res."},{"key":"10.1016\/j.exer.2003.12.007_BIB31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1089\/jop.1996.12.489","article-title":"Ocular hypotensive mechanism of topical isopropyl unoprostone, a novel prostaglandin metabolite-related drug, in rabbits","volume":"12","author":"Taniguchi","year":"1996","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.exer.2003.12.007_BIB32","first-page":"477","article-title":"Aqueous humor dynamics in experimental iridocyclitis","volume":"28","author":"Toris","year":"1987","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2003.12.007_BIB33","first-page":"614","article-title":"Latanoprost and periocular skin color changes","volume":"119","author":"Wand","year":"2001","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2003.12.007_BIB34","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0161-6420(96)30750-1","article-title":"A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension","volume":"103","author":"Watson","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2003.12.007_BIB35","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1016\/S0039-6257(97)80020-3","article-title":"The incidence and time\u2013course of latanoprost-induced iridial pigmentation as a function of eye color","volume":"41","author":"Wistrand","year":"1997","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2003.12.007_BIB36","doi-asserted-by":"crossref","first-page":"S337","DOI":"10.1016\/S0039-6257(01)00224-7","article-title":"The pharmacology of bimatoprost (Lumigan)","volume":"47","author":"Woodward","year":"2001","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2003.12.007_BIB37","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00061198-199712000-00014","article-title":"Iris-color change developed after topical isopropyl unoprostone treatment","volume":"6","author":"Yamamoto","year":"1997","journal-title":"J. Glaucoma"}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483504000053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483504000053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,14]],"date-time":"2021-06-14T06:05:08Z","timestamp":1623650708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483504000053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0014483504000053"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2003.12.007","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}